Items where Funder is National Centre for the Replacement Refinement and Reduction of Animals in Research.

2488438

Derby, S., Dutton, L., Strathdee, K.E. et al. (27 more authors) (2023) Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalisation via macropinocytosis. Neuro-Oncology. noad210. ISSN 1522-8517

NC/R001618/1

Bowley, G. orcid.org/0000-0002-5008-3276, Chico, T.J.A. orcid.org/0000-0002-7458-5481, Serbanovic-Canic, J. orcid.org/0000-0002-8835-1491 et al. (1 more author) (2021) Quantifying endothelial cell proliferation in the zebrafish embryo. F1000Research, 10. 1032. ISSN 2046-1402

NC/T001895/1

Gagg, H. orcid.org/0000-0003-2763-0304, Williams, S.T., Conroy, S. et al. (9 more authors) (2023) Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients. F1000Research, 12. 954. ISSN 2046-1402

NC/T002093/1

Gagg, H. orcid.org/0000-0003-2763-0304, Williams, S.T., Conroy, S. et al. (9 more authors) (2023) Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients. F1000Research, 12. 954. ISSN 2046-1402

Gagg, H. orcid.org/0000-0003-2763-0304, Williams, S.T., Conroy, S. et al. (9 more authors) (2023) Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients. F1000Research, 12. 954. ISSN 2046-1402